| Literature DB >> 34873409 |
Gao-Feng Liu1, Zhen Gao2, Zheng-Nan Liu3, Min Yang4, Sheng Zhang5, Tai-Peng Tan6.
Abstract
BACKGROUND: Temporomandibular joint disorders (TMDs) are a common and prevalent disease with main symptoms of pain, joint sounds, and mandibular movement disorders, which seriously affects the mental health and quality of life of the sufferers. In recent years, there have been an increasing number of studies utilizing warm needle acupuncture (WNA) for the treatment of TMD, and the quality of the studies has gradually improved. However, evidence from evidence-based medicine is lacking. This study aims to use a systematic review and meta-analysis method to understand the efficacy of WNA for the treatment of TMD. Methods and Analysis. We searched randomized controlled trials (RCTs) of WNA for the treatment of TMD from 9 electronic databases, including 5 English databases (PubMed, EMBASE, Cochrane Library, Web of Science, and MEDLINE) and 4 Chinese databases (Chinese National Knowledge Infrastructure (CNKI), Chinese VIP Information, Wanfang Database, and Chinese Biomedical Literature Database (CBM)) from their inception to May 2021. The included RCTs compared WNA with acupuncture, electroacupuncture, pharmacological therapy, or other therapies. And outcome indicators such as total effective rate and cure rate were assessed. All analyses were conducted using RevMan software V5.3 and Stata16. Measurement count data used the relative risk (RR) as the efficacy statistic, and each effect size was given its point estimate value and 95% confidence interval (CI).Entities:
Year: 2021 PMID: 34873409 PMCID: PMC8643238 DOI: 10.1155/2021/6868625
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Search strategy in PubMed.
| NO. | Search details | Results |
|---|---|---|
| #1 | “Temporomandibular joint Disorders”[MeSH terms] | 17827 |
| #2 | (((“Joint s” [All fields] OR “joints” [MeSH terms] OR “joints” [All fields] OR “Joint” [All fields]) AND “disorder | 18806 |
| #3 | #1 AND #2 | 12593 |
| #4 | “Acupuncture” [Title/Abstract] OR “Moxibustion” [Title/Abstract] OR “wen zhen” [Title/Abstract] OR “needle warming moxibustion” [Title/Abstract] OR “needle warming therapy” [Title/Abstract] OR “warm needling” [Title/Abstract] OR “warm acupuncture” [Title/Abstract] OR “warm needle moxibustion” [Title/Abstract] OR (“Warm” [All fields] AND “acupuncture-moxibustion”[Title/Abstract]) OR “warm needle acupuncture” [Title/Abstract] OR (“warming acupuncture” [Title/Abstract] AND “Moxibustion” [Title/Abstract]) | 25076 |
| #5 | #3 AND #4 | 138 |
Figure 1Literature search diagram.
Characteristics information of the included studies.
| Author | Year | Group | Interventions | Sample size | Age (years) | Gender (M/F) |
|---|---|---|---|---|---|---|
| Liao | 2001 | T | WNA | 32 | 15–52 | 21/38 |
| C | Acupuncture | 27 | ||||
| Jin | 2005 | T | WNA | 36 | 19–61 | 10/26 |
| C | Drug therapy | 32 | 21–59 | 8/24 | ||
| He | 2007 | T | WNA | 31 | 20.48 ± 5.30 | NA |
| C | Acupuncture + TDP | 31 | 18.24 ± 5.21 | |||
| Zhong | 2007 | T | WNA | 60 | 35 ± 5 | 30/30 |
| C | Ultrasonic therapy | 60 | 34 ± 4 | 30/30 | ||
| Zhang | 2008 | T | WNA | 23 | 18–55 | 13/10 |
| C | Drug therapy | 22 | 18–55 | 10/12 | ||
| Zhao | 2015 | T | WNA | 36 | 18–45 | 15/21 |
| C | Acupuncture | 36 | 19–50 | 18/18 | ||
| Liu 1 | 2019 | T | WNA | 33 | 48 ± 0 | 14/19 |
| C | Drug therapy | 32 | 49 ± 1 | 15/17 | ||
| Liu 2 | 2019 | T | WNA | 33 | 48.42 ± 0.28 | 14/19 |
| C | Drug therapy | 32 | 48.91 ± 0.67 | 15/17 | ||
| Wang 1 | 2021 | T | WNA | 28 | 44.14 ± 14.16 | 4/24 |
| C | Electroacupuncture | 29 | 39.24 ± 12.97 | 5/24 | ||
| Wang 2 | 2021 | T | WNA | 28 | 44.14 ± 14.16 | 4/24 |
| C | Drug therapy | 29 | 43.91 ± 16.34 | 6/23 |
Note. T = test group, C = control group, I = intervention, M = male, F = female.
Characteristics information of the included studies.
| Author | Year | Course of the disease | Course of treatment | Outcome indicators |
|---|---|---|---|---|
| Liao | 2001 | 7 days–2 years | Once a day, 10 times a course of treatment, 2 courses of treatment. | ①② |
| Jin | 2005 | 1 weeks–8 months | Once a day for 5 days, 1 course of treatment, 1 day interval, consecutive 2 courses of treatment. | ①② |
| 1 weeks–6 months | Diazepam 2.5 mg and indomethacin 25 mg were taken orally, 3 times a day, one course for 5 days, 2 courses. | |||
| He | 2007 | 11.33 ± 4.52 days | Once a day, 10 times a course of treatment, 2 courses of treatment, and the interval of courses is 2–3 days. | ①② |
| 10.44 ± 3.88 days | ||||
| Zhong | 2007 | Once a day for 10 consecutive times. | ①② | |
| Zhang | 2008 | 10 days–6 months | Once a day, 10 times a course of treatment, 2 courses of treatment. | ①② |
| Oral indomethacin 25 mg, 3 times a day and vitamin B1 10 mg, 3 times a day. Mental tension diazepam tablets 2.5 mg, once a day, taken before going to bed. One course of treatment for 10 days, 2 courses. | ||||
| Zhao | 2015 | Less than 6 years | Once a day, 7 times a course of treatment, an interval of 2 days, 2 courses of treatment. | ①② |
| Liu 1 | 2019 | 3.98 ± 1.96 months | The treatment was performed once every other day, 3 times a week for 4 weeks. | ①② |
| 4.27 ± 1.84 months | Oral diclofenac sodium sustained-release capsule (Zhejiang Sincerity Pharmaceutical Co., Ltd.,) (75 mg per granule) twice a day; oral glucosamine hydrochloride tablets (Yongxin Pharmaceutical, 0.24 g per tablet), 0.48 g each time, 3 times a day. Take both drugs for four weeks. | |||
| Liu 2 | 2019 | 3.98 ± 1.96 months | Once every other day, 3 times a week, a total treatment for 4 weeks. | ① |
| 4.27 ± 1.84 months | Oral diclofenac sodium sustained-release capsule (Zhejiang Sincerity Pharmaceutical Co., Ltd.,) (specifications: 75 mg/pill), 1 pill/time, 2 times/d. Glucosamine hydrochloride capsules (Hong Kong Aomei pharmaceutical factory) (specifications: 0.75 g/granule), 1 granule/time, 2 times/d. Both drugs were administered for 4 weeks. | ① | ||
| Wang 1 | 2021 | 10.00 ± 8.87 days | Once a day, 5 times a course of treatment, with a treatment interval of 2 days, for a total of 2 courses. | ①② |
| 8.48 ± 5.88 days | ||||
| Wang 2 | 2021 | 10.00 ± 8.87 days | Once a day, 5 times a course of treatment, with a treatment interval of 2 days, for a total of 2 courses. | ①② |
| 8.28 ± 6.84 days | Voltaren external application is used 3 times a day, 5 times a course, and 2 days rest, for a total of 2 courses. |
Note. T = test group, C = control group, I = intervention, outcome indicators: ① total effective rate; ② cure rate.
Figure 2The risk deviation ratio chart of the included studies.
Figure 3General chart of the methodological quality evaluation of the included studies.
Figure 4Total effective rate forest map.
Figure 5Forest map for total efficiency subgroup analysis.
Figure 6Forest graph of the cure rate.
Figure 7Sensitivity analysis of the total effective rate: the lowest and highest values of the confidence interval were 1.12 and 4.78, respectively; the upper and lower limits of the meta-analysis effect size and the confidence interval were 1.34 and 3.46, respectively.
Figure 8Sensitivity analysis of cure rate: the lowest and highest values of the confidence interval were 0.88 and 3.51, respectively; the upper and lower limits of the meta-analysis effect size and the confidence interval were 1.42 and 3.05, respectively.